Dr. Ivan T. Cakulev, MD
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,474
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
OH license 35-081374 · OH license 35.081374 -
Cardiovascular Disease Physician
OH license 35-081374
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uh Cleveland Medical Center Cleveland, OH
- University Hospitals Ahuja Medical Center Beachwood, OH
- Lake Health Concord, OH
- Uh Regional Hospitals Chardon, OH
- Uhhs Memorial Hospital of Geneva Geneva, OH
Medical groups
- University Hospitals Medical Group Inc (2,294 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,474
- Services billed
- 2,953
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 759 | 574 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 304 | 304 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 173 | 99 |
| Established patient office or other outpatient visit, 30-39 minutes | 150 | 129 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 144 | 109 |
| Programming of dual lead pacemaker system | 106 | 88 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 68 | 68 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 59 | 44 |
| Established patient office or other outpatient visit, 40-54 minutes | 58 | 58 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 53 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Cleveland, OH | 227 |
| Amiodarone Hcl Other prescribers in Cleveland, OH | 70 |
| Metoprolol Tartrate Other prescribers in Cleveland, OH | 70 |
| Dofetilide | 68 |
| Flecainide Acetate Other prescribers in Cleveland, OH | 63 |
| Metoprolol Succinate Other prescribers in Cleveland, OH | 53 |
| Carvedilol Other prescribers in Cleveland, OH | 21 |
| Sotalol (sotalol hcl) Other prescribers in Cleveland, OH | 20 |
| Xarelto (rivaroxaban) Other prescribers in Cleveland, OH | 16 |
| Warfarin Sodium Other prescribers in Cleveland, OH | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 55 payments worth $1,354 in total to this clinician.
| Boston Scientific Corporation | $395 |
|---|---|
| Medtronic, Inc. | $367 |
| Abbott Laboratories | $282 |
| Biosense Webster, Inc. | $171 |
| E.r. Squibb & Sons, L.l.c. | $84.09 |
| Pfizer Inc. | $36.92 |
| Atricure, Inc. | $17.95 |
| Food and Beverage | $1,354 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,137 in research payments for these studies, mostly to the institutions running them.
- Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
Impulse Dynamics (USA) Inc. · Active, not recruiting · NCT03970343
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.